PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'State Key Laboratory of Molecular Biology, State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China.\', \'University of CAS, Beijing, China.\', \'CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai CAS, Shanghai, China.\', \'Hangzhou Center for Disease Control and Prevention, Hangzhou, China.\', \'Erasmus Laboratory Animal Science Center, Erasmus University Medical Center, Rotterdam, The Netherlands.\', \'European Research Infrastructure on Highly Pathogenic Agents (ERINHA-AISBL), Paris, France.\', \'Department of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands.\', \'CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), CAS, Beijing, China.\', \'National Facility for Protein Science in Shanghai, Shanghai Advanced Research Institute (Zhangjiang Laboratory), CAS, Shanghai, China.\', \'Joint Center for Infection and Immunity, Guangzhou Institute of Pediatrics, Guangzhou Women and Children\'s Medical Center, Guangzhou Medical University, Guangzhou, China.\', \'Pasteurien College, Soochow University, Jiangsu, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.15252/emmm.202114544
?:doi
?:hasPublicationType
?:journal
  • EMBO molecular medicine
is ?:pmid of
?:pmid
?:pmid
  • 34672091
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.44
?:rankingScore_hIndex
  • 79
is ?:relation_isRelatedTo_publication of
?:title
  • Uncovering a conserved vulnerability site in SARS-CoV-2 by a human antibody.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all